Ethinylestradiol/norethisterone ultra low dose - Nobelpharma

Drug Profile

Ethinylestradiol/norethisterone ultra low dose - Nobelpharma

Alternative Names: Lunabell tablets ULD; NPC-01

Latest Information Update: 30 Sep 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nobelpharma
  • Developer Nippon Shinyaku; Nobelpharma
  • Class Alkylated estrogenic steroids; Hormonal contraceptives; Norpregnatrienes; Norpregnenes; Small molecules
  • Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Marketed Dysmenorrhoea

Most Recent Events

  • 15 Dec 2016 Biomarkers information updated
  • 26 Sep 2013 Launched for Dysmenorrhoea in Japan (PO)
  • 29 Feb 2012 Nobelpharma completes a phase III trial in Dysmenorrhoea in Japan (NCT00902746)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top